116 related articles for article (PubMed ID: 38494815)
21. [Two Cases of Long-Term Control of Advanced Gastric Cancer Treated with>35 Cycles of Low-Dose Nab-Paclitaxel].
Kawaguchi K; Urayama M; Fujimoto H; Isobe H; Fuse A; Ohta K
Gan To Kagaku Ryoho; 2019 Oct; 46(10):1569-1572. PubMed ID: 31631141
[TBL] [Abstract][Full Text] [Related]
22. Phase 1 Study of Combined Chemotherapy of Nab-Paclitaxel, S-1, and Oxaliplatin for Gastric Cancer with Peritoneal Metastasis (NSOX Study).
Nakamura M; Ojima T; Katsuda M; Hayata K; Kitadani J; Nakamori M; Yamaue H
Oncology; 2021; 99(1):57-61. PubMed ID: 32877909
[TBL] [Abstract][Full Text] [Related]
23. Initial Experience with Nab-Paclitaxel for Patients with Advanced Gastric Cancer: Safety and Efficacy.
Kanazawa Y; Fujita I; Kakinuma D; Arai H; Matsuno K; Shimoda T; Ko K; Kato S; Uchida E
Anticancer Res; 2017 May; 37(5):2715-2720. PubMed ID: 28476850
[TBL] [Abstract][Full Text] [Related]
24. Nab-paclitaxel maintenance therapy following carboplatin + nab-paclitaxel combination therapy in chemotherapy naïve patients with advanced non-small cell lung cancer: multicenter, open-label, single-arm phase II trial.
Nakao A; Uchino J; Igata F; On R; Ikeda T; Yatsugi H; Hirano R; Sasaki T; Tanimura K; Imabayashi T; Tamiya N; Kaneko Y; Yamada T; Nagata N; Watanabe K; Kishimoto J; Takayama K; Fujita M
Invest New Drugs; 2018 Oct; 36(5):903-910. PubMed ID: 29846848
[TBL] [Abstract][Full Text] [Related]
25. Successful Long-term Management with a Single Administration of Tri-weekly Nab-paclitaxel in a Patient with Advanced Gastric Cancer with Peritoneal Dissemination.
Matano D; Moriwaki T; Tange Y; Niisato Y; Yamaura M; Nagase M; Suganuma D; Takagi Taketa K; Iwai K; Enami C; Yamamoto Y; Hyodo I
Intern Med; 2017; 56(8):921-923. PubMed ID: 28420840
[TBL] [Abstract][Full Text] [Related]
26. Effect of early tumor response on the health-related quality of life among patients on second-line chemotherapy for advanced gastric cancer in the ABSOLUTE trial.
Fujitani K; Shitara K; Takashima A; Koeda K; Hara H; Nakayama N; Hironaka S; Nishikawa K; Kimura Y; Amagai K; Hosaka H; Komatsu Y; Shimada K; Kawabata R; Ohdan H; Kodera Y; Nakamura M; Nakajima TE; Miyata Y; Moriwaki T; Kusumoto T; Nishikawa K; Ogata K; Shimura M; Morita S; Koizumi W
Gastric Cancer; 2021 Mar; 24(2):467-476. PubMed ID: 33136231
[TBL] [Abstract][Full Text] [Related]
27. A Phase II Study of Tri-weekly Low-dose Nab-paclitaxel Chemotherapy for Patients with Advanced Gastric Cancer.
Sato S; Kunisaki C; Tanaka Y; Sato K; Miyamoto H; Yukawa N; Fujii Y; Kimura J; Takagawa R; Takahashi M; Kosaka T; Akiyama H; Saigusa Y; Taguri M; Yamanaka T; Endo I
Anticancer Res; 2018 Dec; 38(12):6911-6917. PubMed ID: 30504409
[TBL] [Abstract][Full Text] [Related]
28. Phase II trial of paclitaxel by three-hour infusion for advanced gastric cancer with short premedication for prophylaxis against paclitaxel-associated hypersensitivity reactions.
Yamada Y; Shirao K; Ohtsu A; Boku N; Hyodo I; Saitoh H; Miyata Y; Taguchi T
Ann Oncol; 2001 Aug; 12(8):1133-7. PubMed ID: 11583196
[TBL] [Abstract][Full Text] [Related]
29. Oxaliplatin, 5-Fluorouracil and Nab-paclitaxel as perioperative regimen in patients with resectable gastric adenocarcinoma: A GERCOR phase II study (FOXAGAST).
Watson S; de la Fouchardière C; Kim S; Cohen R; Bachet JB; Tournigand C; Ferraz JM; Lefevre M; Colin D; Svrcek M; Meurisse A; Louvet C
Eur J Cancer; 2019 Jan; 107():46-52. PubMed ID: 30529902
[TBL] [Abstract][Full Text] [Related]
30. A clinical trial to assess the feasibility and efficacy of nab-paclitaxel plus gemcitabine for elderly patients with unresectable advanced pancreatic cancer.
Hasegawa R; Okuwaki K; Kida M; Yamauchi H; Kawaguchi Y; Matsumoto T; Kaneko T; Miyata E; Uehara K; Iwai T; Watanabe M; Kurosu T; Imaizumi H; Ohno T; Koizumi W
Int J Clin Oncol; 2019 Dec; 24(12):1574-1581. PubMed ID: 31309381
[TBL] [Abstract][Full Text] [Related]
31. Superior therapeutic efficacy of nab-paclitaxel over cremophor-based paclitaxel in locally advanced and metastatic models of human pancreatic cancer.
Rajeshkumar NV; Yabuuchi S; Pai SG; Tong Z; Hou S; Bateman S; Pierce DW; Heise C; Von Hoff DD; Maitra A; Hidalgo M
Br J Cancer; 2016 Aug; 115(4):442-53. PubMed ID: 27441498
[TBL] [Abstract][Full Text] [Related]
32. Adjuvant albumin-bound paclitaxel combined with S-1 vs. oxaliplatin combined with capecitabine after D2 gastrectomy in patients with stage III gastric adenocarcinoma: a phase III multicenter, open-label, randomized controlled clinical trial protocol.
Cheng X; Wu D; Xu N; Chen L; Yan Z; Chen P; Zhou L; Yu J; Cui J; Li W; Wang C; Feng W; Wei Y; Yu P; Du Y; Ying J; Xu Z; Yang L; Zhang Y
BMC Cancer; 2021 Jan; 21(1):56. PubMed ID: 33435909
[TBL] [Abstract][Full Text] [Related]
33. [A Thoracic Aortic Dissection Case during Treatment with Ramucirumab plus Nab-Paclitaxel].
Nikai H; Akiyama Y; Fujisawa R; Endo F; Baba S; Koeda K; Sasaki A
Gan To Kagaku Ryoho; 2020 Jun; 47(6):981-983. PubMed ID: 32541179
[TBL] [Abstract][Full Text] [Related]
34. Superior antitumor activity of nanoparticle albumin-bound paclitaxel in experimental gastric cancer.
Zhang C; Awasthi N; Schwarz MA; Hinz S; Schwarz RE
PLoS One; 2013; 8(2):e58037. PubMed ID: 23460921
[TBL] [Abstract][Full Text] [Related]
35. Phase II Study of Modified Carboplatin Plus Weekly Nab-Paclitaxel in Elderly Patients with Non-Small Cell Lung Cancer: North Japan Lung Cancer Study Group Trial 1301.
Miyauchi E; Inoue A; Usui K; Sugawara S; Maemondo M; Saito H; Fujita Y; Kato T; Suzuki T; Harada T; Watanabe H; Nakagawa T; Ichinose M
Oncologist; 2017 Jun; 22(6):640-e59. PubMed ID: 28526722
[TBL] [Abstract][Full Text] [Related]
36. Nanoparticle albumin-bound paclitaxel (nab-paclitaxel) as second-line chemotherapy in HER2-negative, taxane-pretreated metastatic breast cancer patients: prospective evaluation of activity, safety, and quality of life.
Palumbo R; Sottotetti F; Trifirò G; Piazza E; Ferzi A; Gambaro A; Spinapolice EG; Pozzi E; Tagliaferri B; Teragni C; Bernardo A
Drug Des Devel Ther; 2015; 9():2189-99. PubMed ID: 25931813
[TBL] [Abstract][Full Text] [Related]
37. Nanoparticle albumin-bound paclitaxel in elder patients with advanced squamous non-small-cell lung cancer: A retrospective study.
Liu Y; Dong Y; Zhu H; Jing W; Guo H; Yu J
Cancer Med; 2020 Feb; 9(4):1365-1373. PubMed ID: 31876976
[TBL] [Abstract][Full Text] [Related]
38. Efficacy and Safety of Paclitaxel/nab-paclitaxel Chemotherapy for Patients With Relapsed Small Cell Lung Cancer.
Matsui Y; Yamada T; Morimoto K; Katayama Y; Hiranuma O; Shiotsu S; Tamiya N; Takeda T; Morimoto Y; Iwasaku M; Tokuda S; Takayama K
Anticancer Res; 2022 Oct; 42(10):4921-4928. PubMed ID: 36191970
[TBL] [Abstract][Full Text] [Related]
39. Second-line chemotherapy with paclitaxel and doxifluridine after failure of S-1 in elderly patients with unresectable advanced or recurrent gastric cancer.
Yakabe T; Noshiro H; Ikeda O; Miyoshi A; Kitajima Y; Satoh S
J Cancer Res Clin Oncol; 2011 Oct; 137(10):1499-504. PubMed ID: 21830159
[TBL] [Abstract][Full Text] [Related]
40. [Nanoparticle albumin-bound Paclitaxel for unresectable or recurrent gastric cancer].
Egawa T; Kemmochi T; Nishiya S; Mihara K; Ito Y; Nagashima A
Gan To Kagaku Ryoho; 2014 Nov; 41(12):2251-3. PubMed ID: 25731486
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
